CreditReports.dk
HomeScreen companies

ASCENDIS PHARMA BONE DISEASES A/S Financials, key figures and credit report

CVR number: 32323596 Established 2012 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Tuborg Boulevard 12, 2900 Hellerup
Gross profit 229 581.0 kEUR FY 2025 +774.9% vs 2024
EBIT 157 422.0 kEUR FY 2025 +245.1% vs 2024
Net debt 429 672.0 kEUR FY 2025 -17.7% vs 2024
Quick ratio 0.4 FY 2025 +0 vs 2024

Company information

Official name
ASCENDIS PHARMA BONE DISEASES A/S
Established
2012
Company form
Limited company
Industry

Data sources and methodology

The information about ASCENDIS PHARMA BONE DISEASES A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About ASCENDIS PHARMA BONE DISEASES A/S

ASCENDIS PHARMA BONE DISEASES A/S (CVR number: 3232359-6) is a company from GENTOFTE. The company recorded a gross profit of 229.6 mEUR in 2025. The operating profit was 157.4 mEUR, while net earnings were 135 mEUR. The profitability of the company measured by Return on Assets (ROA) was 43.4 %, which can be considered excellent and Return on Equity (ROE) was 364 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at -86.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA BONE DISEASES A/S's liquidity measured by quick ratio was 0.4 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.

Financial information

See financials

Gross profit (kEUR)

EBIT (kEUR)

Profitability

Solidity

Key figures (kEUR)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit-57 981.88-66 598.34- 112.33-34 018.00229 581.00
EBIT-58 098.50-66 714.83- 112.36- 108 477.00157 422.00
Net earnings-61 825.26-72 197.54- 118.96- 139 088.00134 982.00
Shareholders equity total- 176 972.22- 249 169.77- 368.13- 507 165.00- 372 183.00
Balance sheet total (assets)18 338.8118 541.3939.6115 431.0058 737.00
Net debt195 302.70267 659.13382.24521 914.00429 672.00
Profitability
EBIT-%
ROA-35.4 %-28.8 %-0.1 %-41.1 %43.4 %
ROE- 339.0 %- 391.5 %-1.3 %-1 798.1 %364.0 %
ROI-35.9 %-28.8 %-0.1 %-41.1 %43.5 %
Economic value added (EVA)-58 639.54-67 541.98-1 043.59- 108 077.27156 611.40
Solvency
Equity ratio-90.6 %-93.1 %-90.3 %-97.0 %-86.4 %
Gearing- 110.4 %- 107.4 %- 110.8 %- 102.9 %- 115.5 %
Relative net indebtedness %
Liquidity
Quick ratio719.7753.93 649.10.40.4
Current ratio719.7753.93 649.10.40.4
Cash and cash equivalents2.4546.1225.49176.0036.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
43.4%
Rating 91/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
-86.4%
Rating 0/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of ASCENDIS PHARMA BONE DISEASES A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated